| Cat. No. |
Product Name |
Information |
| PC-24340 |
DNA gyrase inhibitor 35
2088347-91-3
|
DNA gyrase inhibitor 35 is potent small molecule DNA gyrase inhibitor with IC50 of 1.2 μM of E.coli DNA gyrase, also shows low micromolar inhibition of E. coli topoisomerase IV and of the respective Staphylococcus aureus homologues. |
| PC-24339 |
Astrazeneca Arylaminotriazine
DNA gyrase inhibitor
|
Astrazeneca Arylaminotriazine is a promising DNA gyrase inhibitor with profound antibacterial activity. |
| PC-24338 |
10-F05
FabH/MiaA inhibitor
|
10-F05 is a covalent small molecule inhibitor of bacterial β-ketoacyl-acyl carrier protein synthase III (FabH) and MiaA tRNA prenyltransferase, demonstrates broad-spectrum antibacterial effectiveness (MIC=2.5 uM, S. flexneri). |
| PC-24315 |
Lariocidin
Antibiotic
|
Lariocidin (LAR) is a novel ribosome-targeting lasso peptide antibiotic inhibit bacterial growth by binding to the ribosome and interfering with protein synthesis. |
| PC-24305 |
P2-56-3
Rifampin potentiator
|
P2-56-3 is small-molecule sensitizer of antibiotic-resistant gram-negative ESKAPE pathogens, potentiates rifampin against antibiotic-resistant strains of Acinetobacter baumannii and Klebsiella pneumoniae, disrupts the outer membrane of A. baumannii. |
| PC-24304 |
Rifampin
Antibiotic
|
Rifampin (Rifampicin) is a potent and broad spectrum antibiotic against bacterial pathogens, also has anti-influenza virus and anti-orthopoxvirus activities. |
| PC-24301 |
Fosfomycin sodium
Antibiotic
|
Fosfomycin (MK-0955) sodium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis, shows a wide range antibacterial activity, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria. |
| PC-24300 |
Fosfomycin calcium
Antibiotic
|
Fosfomycin (MK-0955) calcium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis, shows a wide range antibacterial activity, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria. |
| PC-24201 |
ChlaDUB1 inhibitor 27a
ChlaDUB1 inhibitor
|
ChlaDUB1 inhibitor 27a is a specific covalent inhibitor of bacterial chlamydial deubiquitinase 1 (ChlaDUB1) with IC50 of 0.97 uM, inhibits chlamydial growth with IC50 of 25.6 ug/mL. |
| PC-24194 |
Xeruborbactam isoboxil
Beta-lactamase inhibitor
|
Xeruborbactam isoboxil is the prodrug of xeruborbactam, an ultrabroad-spectrum beta-lactamase inhibitor, inhibits class A extended-spectrum beta-lactamases with IC50 of 1-3 nM, carbapenemases such as KPC (IC50, 2.9 nM), class C P99 (IC50, 22 nM). |
| PC-24024 |
MraY inhibitor 12a
MraY inhibitor
|
MraY inhibitor 12a is a first-in-class, non-nucleoside inhibitor of bacterial enzyme MraY with IC50 of 25 uM, exhibits broad-spectrum antibacterial activity. |
| PC-23990 |
Enoxacin
DNA Gyrase inhibitor
|
Enoxacin (Enoxacin sesquihydrate) is a fluoroquinolone antibiotic, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 µg/ml) and topoisomerase IV (IC50=26.5 µg/ml). Enoxacin is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin shows potent activities against gram-positive and -negative bacteria. Enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-bi |